IDEXX LABORATORIES INC /DE (IDXX) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Idexx Laboratories Inc /De quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Idexx Laboratories Inc /De Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was $4.68 B, a 22.7% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $4.68 B +$867 M +22.7% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $4.44 B +$845 M +23.5% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 $4.25 B +$823 M +24% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $4.04 B +$791 M +24.4% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $3.81 B +$699 M +22.5% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $3.6 B +$679 M +23.3% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $3.43 B +$670 M +24.3% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $3.25 B +$664 M +25.7% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $3.11 B +$735 M +30.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $2.92 B +$745 M +34.2% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $2.76 B +$757 M +37.8% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $2.58 B +$728 M +39.2% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $2.38 B +$674 M +39.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $2.18 B +$580 M +36.3% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $2 B +$496 M +32.9% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $1.85 B +$458 M +32.8% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $1.71 B +$435 M +34.2% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $1.6 B +$428 M +36.6% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $1.51 B +$423 M +39.1% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $1.4 B +$407 M +41.2% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.27 B +$390 M +44.3% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $1.17 B +$364 M +45.3% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $1.08 B +$317 M +41.4% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $989 M +$294 M +42.4% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $880 M +$271 M +44.5% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $804 M +$263 M +48.7% Dec 31, 2017 10-K 2019-02-15
Q3 2017 $765 M +$277 M +56.8% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $695 M +$263 M +61% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $609 M +$245 M +67.3% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $540 M +$222 M +69.7% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $488 M +$214 M +78.1% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $432 M +$201 M +86.8% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 $364 M -$1.36 B -78.8% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $318 M -$1.36 B -81% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $274 M -$1.38 B -83.4% Sep 30, 2015 10-Q 2015-10-28
Q2 2015 $231 M -$1.37 B -85.5% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 $1.72 B +$182 M +11.8% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $1.68 B +$182 M +12.2% Dec 31, 2014 10-K 2016-02-17
Q3 2014 $1.65 B +$199 M +13.7% Sep 30, 2014 10-Q 2014-10-24
Q2 2014 $1.6 B +$193 M +13.7% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 $1.54 B +$190 M +14% Mar 31, 2014 10-Q 2014-04-25
Q4 2013 $1.49 B +$188 M +14.4% Dec 31, 2013 10-K 2015-02-17
Q3 2013 $1.45 B +$188 M +14.9% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 $1.4 B +$185 M +15.2% Jun 30, 2013 10-Q 2013-07-23
Q1 2013 $1.35 B +$182 M +15.6% Mar 31, 2013 10-Q 2013-04-23
Q4 2012 $1.31 B +$178 M +15.8% Dec 31, 2012 10-K 2014-02-18
Q3 2012 $1.26 B +$173 M +15.9% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 $1.22 B +$169 M +16% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 $1.17 B +$166 M +16.6% Mar 31, 2012 10-Q 2012-04-20
Q4 2011 $1.13 B +$162 M +16.8% Dec 31, 2011 10-K 2013-02-19
Q3 2011 $1.09 B +$160 M +17.2% Sep 30, 2011 10-Q 2011-10-21
Q2 2011 $1.05 B +$156 M +17.5% Jun 30, 2011 10-Q 2011-07-22
Q1 2011 $1 B Mar 31, 2011 10-Q 2011-04-21
Q4 2010 $966 M Dec 31, 2010 10-K 2012-02-17
Q3 2010 $929 M Sep 30, 2010 10-Q 2010-10-22
Q2 2010 $894 M Jun 30, 2010 10-Q 2010-07-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.